Net income of Charles River Laboratories International under GAAP for the 3 months of 2022 was $95.226 million, up 48.9% from $63.935 million in the previous year. Revenue increased 10.8% to $913.929 million from $824.566 million a year earlier.
Net income of Charles River Laboratories International under GAAP for the 3 months of 2022 was $95.226 million, up 48.9% from $63.935 million in the previous year. Revenue increased 10.8% to $913.929 million from $824.566 million a year earlier. 
ir.criver.com
English (US) 